Literature DB >> 24664750

High glucose activates ChREBP-mediated HIF-1α and VEGF expression in human RPE cells under normoxia.

Min-Lee Chang1, Chung-Jung Chiu, Fu Shang, Allen Taylor.   

Abstract

OBJECTIVE: Because retina-damaging angiogenesis is controlled by vascular endothelial growth factor (VEGF) and people with higher glucose intakes are more susceptible to retinal complications that may be due to increased VEGF, it is crucial to elucidate relations between glucose exposure and VEGF expression. We aimed to determine if a carbohydrate response element binding protein (ChREBP) plays a role in the transcriptional up-regulation of hypoxia-inducible factor-1α (HIF-1α) and the downstream VEGF expression in retinal pigment epithelial (RPE) cells exposed to high glucose under normoxic conditions.
METHODS: ARPE19 cells were exposed to 5.6, 11, 17, 25 and 30 mM glucose for 48 h in serum-free culture media under normoxic (21 % O2) conditions. Protein and mRNA expression of indicated genes were determined by immunoblot analyses and real-time RT-PCR, respectively. An enzyme-linked immunosorbent assay (ELISA) was used to detect the concentrations of VEGF in the media. Immunofluorescence (IF) and chromatin immunoprecipitation (ChIP) for ChREBP were used to demonstrate nuclear translocation and HIF-1α gene promoter association, respectively.
RESULTS: Immunoblot analyses showed that HIF-1α levels were positively related to levels of glucose exposure between 5.6-25 mM in the RPE cells, indicating the induction and stabilization of HIF-1α by elevated glucose under normoxic conditions. Human lens epithelial cells and HeLa cells did not respond to high glucose, implying that this phenomenon is cell type-specific. Real-time RT-PCR for HIF-1α and VEGF and ELISA for VEGF indicated that high glucose is associated with elevated production of HIF-1α-induced VEGF, an established inducer of neovascularization, in the RPE cells. IF analyses showed that, although ChREBP was expressed under both low (5.6 mM) and high (25 mM) glucose conditions, it appeared more in the nuclear region than in the cytosol of the RPE cells after the high glucose treatment. ChIP analyses suggested a HIF-1α gene promoter association with ChREBP under the high glucose condition. These results imply that RPE cells use cytosolic ChREBP as a glucose sensor to up-regulate HIF-1α expression.
CONCLUSION: These results suggest a high glucose-induced, ChREBP-mediated, and normoxic HIF-1α activation that may be partially responsible for neovascularization in both diabetic and age-related retinopathy.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24664750     DOI: 10.1007/978-1-4614-3209-8_77

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  10 in total

1.  Diabetic retinal pigment epitheliopathy: fundus autofluorescence and spectral-domain optical coherence tomography findings.

Authors:  Eui Chun Kang; Yuri Seo; Suk Ho Byeon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-06       Impact factor: 3.117

2.  High glucose facilitated endothelial heparanase transfer to the cardiomyocyte modifies its cell death signature.

Authors:  Fulong Wang; Jocelyn Jia; Nathaniel Lal; Dahai Zhang; Amy Pei-Ling Chiu; Andrea Wan; Israel Vlodavsky; Bahira Hussein; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2016-12       Impact factor: 10.787

3.  β-elemene down-regulates HIF-lα, VEGF and iNOS in human retinal pigment epithelial cells under high glucose conditions.

Authors:  Yun Zhou; Jun Chen; Li-Hua Li; Lei Chen
Journal:  Int J Ophthalmol       Date:  2020-12-18       Impact factor: 1.779

4.  The relationship of major American dietary patterns to age-related macular degeneration.

Authors:  Chung-Jung Chiu; Min-Lee Chang; Fang Fang Zhang; Tricia Li; Gary Gensler; Molly Schleicher; Allen Taylor
Journal:  Am J Ophthalmol       Date:  2014-04-29       Impact factor: 5.258

5.  A novel and atypical NF-KB pro-inflammatory program regulated by a CamKII-proteasome axis is involved in the early activation of Muller glia by high glucose.

Authors:  Diego Sbardella; Grazia Raffaella Tundo; Alice Mecchia; Camilla Palumbo; Maria Grazia Atzori; Lauretta Levati; Alessandra Boccaccini; Anna Maria Caccuri; Paolo Cascio; Pedro Miguel Lacal; Grazia Graziani; Monica Varano; Massimiliano Coletta; Mariacristina Parravano
Journal:  Cell Biosci       Date:  2022-07-16       Impact factor: 9.584

6.  Astrocytic responses to high glucose impair barrier formation in cerebral microvessel endothelial cells.

Authors:  Jodi Garvin; Marharyta Semenikhina; Qiuli Liu; Kevin Rarick; Elena Isaeva; Vladislav Levchenko; Alexander Staruschenko; Oleg Palygin; David Harder; Susan Cohen
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2022-04-12       Impact factor: 3.210

Review 7.  Models of retinal diseases and their applicability in drug discovery.

Authors:  Goldis Malek; Julia Busik; Maria B Grant; Mayur Choudhary
Journal:  Expert Opin Drug Discov       Date:  2018-01-30       Impact factor: 6.098

8.  Parenchymal and Stromal Cells Contribute to Pro-Inflammatory Myocardial Environment at Early Stages of Diabetes: Protective Role of Resveratrol.

Authors:  Monia Savi; Leonardo Bocchi; Roberto Sala; Caterina Frati; Costanza Lagrasta; Denise Madeddu; Angela Falco; Serena Pollino; Letizia Bresciani; Michele Miragoli; Massimiliano Zaniboni; Federico Quaini; Daniele Del Rio; Donatella Stilli
Journal:  Nutrients       Date:  2016-11-16       Impact factor: 5.717

9.  Visualization of Dietary Patterns and Their Associations With Age-Related Macular Degeneration.

Authors:  Chung-Jung Chiu; Min-Lee Chang; Tricia Li; Gary Gensler; Allen Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-03-01       Impact factor: 4.799

10.  Transcription Factor ChREBP Mediates High Glucose-Evoked Increase in HIF-1α Content in Epithelial Cells of Renal Proximal Tubules.

Authors:  Aleksandra Owczarek; Katarzyna B Gieczewska; Robert Jarzyna; Zuzanna Frydzinska; Katarzyna Winiarska
Journal:  Int J Mol Sci       Date:  2021-12-10       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.